Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant 4-1BB (Utomilumab Biosimilar) antibody

Research Grade Reactivity: Human ELISA, WB Host: Human Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7538049
  • Target See all 4-1BB (Utomilumab Biosimilar) products
    4-1BB (Utomilumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    Human
    Clonality
    • 1
    Monoclonal
    Conjugate
    • 1
    This 4-1BB (Utomilumab Biosimilar) antibody is un-conjugated
    Application
    ELISA, Western Blotting (WB)
    Purpose
    Utomilumab Biosimilar - Anti-Human TNFRSF9 mAb - Research Grade
    Characteristics
    Antibody Type: IgG2 kappa
    Purity
    > 85%
    Grade
    Research Grade
    Isotype
    IgG2
  • Restrictions
    For Research Use only
  • Buffer
    PBS pH 7.5
    Storage
    4 °C,-20 °C
    Storage Comment
    4°C for short term, -20°C for long term
  • Target
    4-1BB (Utomilumab Biosimilar)
    Abstract
    4-1BB (Utomilumab Biosimilar) Products
    Background
    Utomilumab is a monoclonal antibody that binds to 4-IBB protein (also known as CD137 protein). 4-IBB protein is a receptor found in different immune cells such as helper T-cells, killer T-cells and natural killer cells. 4-IBB/CD137 protein is a costimulatory receptor whose activation results in a series of events that leads to cytokine secretion and effector functions. Hence, targeting CD137 protein has been linked to antitumor immunity response and overall tumor reduction. Indeed, once utomilumab is injected in the bloodstream its specific binding to CD137 protein stimulates the immune cells which, as a result, enhances the immune response against tumors.
    CAS-No
    1417318-27-4
You are here: